Company profile: TransMedics
1.1 - Company Overview
Company description
- Provider of organ preservation technology and clinical service solutions for transplantation, offering OCS Heart, OCS Lung, and OCS Liver systems that keep donor organs functional for viability assessment and transport; the National OCS Program with technology, clinical services, and training; and the OCS Lung Solution for flushing, storage, and transportation.
Products and services
- OCS Lung: Outside-the-body preservation system that keeps donor lungs functioning throughout transport and allows viability assessment during transport
- OCS Heart: Portable preservation system maintaining donor hearts in a metabolically active state for assessment and transport
- OCS Liver: Near-physiological preservation device that maintains donor livers in a near-physiological state and enables viability assessment outside the body during evaluation
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to TransMedics
Verici Dx
HQ: United States
Website
- Description: Provider of RNA signature-based diagnostics for kidney transplant patients, offering pre- and post-transplant prognostic tests—Clarava to predict early rejection risk and Tutivia to assess post-transplant rejection risk—and RNA Signature Tests that provide insights into immune response and transplant prognosis, while tracking patient records and the patient journey.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Verici Dx company profile →
OrganOx
HQ: United Kingdom
Website
- Description: Provider of normothermic machine perfusion technology for donor livers via OrganOx metra, enabling functional assessment and preservation for up to 24 hours. Offerings support evaluation of liver function prior to transplantation, provide more flexible transplant logistics and surgery scheduling, and support complex or lengthy surgeries by extending preservation time.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OrganOx company profile →
Oxford Immunotec
HQ: United Kingdom
Website
- Description: Provider of medical diagnostic tests based on patented T cell measurement technology, including T-SPOT.TB, an interferon gamma release assay for diagnosing latent TB infection and TB disease; T-SPOT.CMV for detecting cytomegalovirus infections; and T-SPOT.PRT for assessing immune responses to various pathogens.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Oxford Immunotec company profile →
OSE Immunotherapeutics
HQ: France
Website
- Description: Provider of immunotherapies in immuno-oncology, auto-immune diseases, and transplantation, with a pipeline including Tedopi (Phase 3 cancer vaccine for NSCLC resistant to checkpoint inhibitors), OSE-279 (anti-PD1), BI 765063/OSE-172 (SIRPα), OSE-127 (IL-7R; ulcerative colitis), FR104 (CD28; renal transplantation), and OSE-230 (ChemR23; chronic inflammatory diseases).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OSE Immunotherapeutics company profile →
Lifeline Scientific
HQ: United States
Website
- Description: Provider of medical technology products and services for cell, tissue, and organ transplantation in the U.S. and internationally, including the LifePort Kidney Transporter for kidney preservation, evaluation, and transport, the LifePort Liver Transporter, and T3 (Tissue Testing Technologies), a cryobiology lab developing preservation and transport methods for transplantation and other biomedical applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lifeline Scientific company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for TransMedics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to TransMedics
2.2 - Growth funds investing in similar companies to TransMedics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for TransMedics
4.2 - Public trading comparable groups for TransMedics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →